PTIXOTCPharmaceutical PreparationsFiscal year ends March 31

Protagenic Therapeutics, Inc.\new

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026

$0.75+0.00 (0.00%)

Close on Oct 19, 2026

Community

Notes and questions about Protagenic Therapeutics, Inc.\new from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Protagenic Therapeutics, Inc.\new's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-14 reverse split on May 13, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PTIX.

Advertisement
300 × 250